Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney

Clinical Trial Summary

Phase III, multicenter, randomized, open, controlled clinical trial. A study designed as phase III, in 120 patients with chronic renal failure in the pre-dialysis stage, evaluate efficacy and safety of Hemax PFS® (PFS: prefilled syringes) vs the innovator erythropoietin alfa product (Eprex®).

See also
Status	Clinical Trial	Phase
Completed	`NCT03325621` - Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients	Phase 1/Phase 2
Completed	`NCT02198495` - Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients	Phase 4
Suspended	`NCT03193073` - Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient	N/A
Completed	`NCT02581124` - Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease	Phase 1
Completed	`NCT02268994` - KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD	Phase 3
Completed	`NCT04543812` - PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD	Phase 3
Recruiting	`NCT05900635` - Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients	Phase 4
Completed	`NCT04667533` - Desidustat in the Treatment of Chemotherapy Induced Anemia	Phase 1
Completed	`NCT03731741` - Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?	Phase 2
Completed	`NCT02787824` - Periodic Versus Continuous IV Iron Supplementation in HD Patients	Phase 4
Completed	`NCT03431623` - CKD-11101 Phase 3 SC Study	Phase 3
Completed	`NCT01971164` - Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease	Phase 1
Recruiting	`NCT01532349` - Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease	Phase 2
Completed	`NCT05698420` - Investigation of the Effects of Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical and Laboratory Parameters of Prevalent Hemodialysis Patients
Completed	`NCT03427801` - Effect of Erythropoiesis-Stimulating Agent Therapy in Patients Receiving Palliative Care of Chronic Kidney Disease
Recruiting	`NCT03521713` - To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)	Phase 3
Active, not recruiting	`NCT02754167` - Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients	Phase 1/Phase 2
Completed	`NCT02805244` - Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis	Phase 1
Completed	`NCT03428594` - CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis	Phase 3
Recruiting	`NCT06463236` - Clinical Validation of the Management Process for Renal Anemia in Maintenance Hemodialysis Patients	N/A

NCT number	NCT04036253
Study type	Interventional
Source	Bio Sidus SA
Contact
Status	Active, not recruiting
Phase	Phase 3
Start date	February 28, 2018
Completion date	January 30, 2022

Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms